Clinical Trial Update: Abiraterone, Radiotherapy and Short-Term Androgen Deprivation in Unfavorable Localized Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial assessing abiraterone with radiotherapy and short-term androgen deprivation in unfavorable localized prostate cancer completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Abiraterone (abiraterone)

Snippet

Sponsor: Duke University | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-09-24